Browsing Tag
NASDAQ
807 posts
SAP completes $1.5bn WalkMe acquisition, enhancing digital adoption capabilities
SAP SE (NYSE: SAP) announced the successful completion of its acquisition of WalkMe Ltd., a company renowned for…
Achilles Therapeutics shares skyrocket 32% after massive cost cuts—Is this the turnaround it needs?
Achilles Therapeutics PLC saw its American Depositary Receipts (ADRs) soar by an impressive 32%, reflecting renewed investor optimism…
Cibus stock crashes as investors panic over sudden public offering move
Cibus Inc., an agricultural biotechnology company specialising in gene editing, saw its shares tumble after announcing an underwritten…
Netcapital shares plunge on 91% revenue decline in first quarter 2025
Shares of Netcapital Inc., a digital private capital markets ecosystem, nosedived after the company reported a dramatic 91%…
Exicure’s stock explodes 78% overnight – but is the comeback for real?
Shares of biopharmaceutical company Exicure Inc. skyrocketed by 78% in after-hours trading, closing at $2.84. The surge came…
Centessa Pharmaceuticals pulls off massive $225m deal—Stock price jumps
Centessa Pharmaceuticals has experienced a substantial rise in its share price after completing an upsized public offering of…
Lovesac stock skyrockets 25% – Is this the next big retail sensation?
Lovesac, the innovative home furnishing company known for its unique modular furniture, saw its shares soar by 25%…
ConnectOne Bancorp to merge with The First of Long Island to create $14bn bank
ConnectOne Bancorp, Inc. (Nasdaq: CNOB), the parent company of ConnectOne Bank, announced a definitive merger agreement with The…
Shoe Carnival shares explode 13%! Discover how back-to-school sales sparked this rally
Shares of Shoe Carnival Inc. jumped 13% to $42.64 in recent trading after the company reported blockbuster second-quarter…
Biopharma shake-up: Semnur Pharmaceuticals to merge with Denali Capital in $2.5bn deal
In a significant development within the biopharmaceutical industry, Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex…